Toxic epidermal necrolysis in a burns centre: A 6-year review

Burns

Volumn 22, Issue 4, 1996, Pages 275-278

  Khoo, Andrew K M ^a   Foo, C L ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BODY SURFACE; CHINESE MEDICINE; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; HEALING; HUMAN; LENGTH OF STAY; MALE; MEDICAL SPECIALIST; MORTALITY; MUCOSA INFLAMMATION; RETROSPECTIVE STUDY; SCHOOL CHILD; SEPSIS; SYMPTOM; TEAMWORK; TIME; TOXIC EPIDERMAL NECROLYSIS;

EID: 0029975176     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/0305-4179(95)00140-9     Document Type: Review

References (21)

1. Avakian R, Flowers FP, Araujo OE, Ramos-Caro FA. Toxic epidermal necrolysis: a review. J Am Acad Dermatol 1991; 25: 69-79.
2. Lyell A. Toxic epidermal necrolysis: an eruption resumbling scalding of the skin. Br J Dermatol 1956; 68: 355-361.
3. Roujeau JC, Revuz J. Toxic epidermal necrolysis: an expanding field of knowledge. J Am Acad Dermatol 1994; 31: 301-302.
4. Bastuji-Garin S, Rzany B, Stern RS. A clinical classification of cases of toxic epidermal necrolysis. Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 1993; 129: 92-96.
5. Lyell A. A review of toxic epidermal necrolysis in Britain. Br J Dermatol 1967; 79: 662-671.
6. Chan HL. Observations on drug-induced toxic epidermal necrolysis in Singapore. J Am Acad Dermatol 1984; 10: 973-978.
7. Heimbach DM, Engrav LH, Marvin JA. Toxic epidermal necrolysis, a step forward in treatment. JAMA 1987; 257: 2171-2175.
8. Ronjeau JC, Guillaune JC, Fabre JC. Toxic epidermal necrolysis (Lyell syndrome), incidence and drug etiology in France. Arch Dermatol 1990; 126: 37-42.
9. Naldi L, Locati L, Marchesi L. Incidence of toxic epidermal necrolysis in Italy. Arch Dermatol 1990; 126: 1103-1004.
10. Schopf E, Stuhmer A, Rzany B. Toxic epidermal necrolysis and Stevens-Johnson syndrome; an epidemiological study from West Germany. Arch Dermatol 1990; 127: 839-847.
11. Guillame JC, Roujeau JC, Revus J. The culprit drugs of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol 1987; 123: 1166-1170.
12. Amon RB, Dimond DL. Toxic epidermal necrolysis, rapid differentiation between staphylococcal and drug-induced disease. Arch Dermatol 1975; 111: 1433-1437.
13. Burleson R. Effect of skin dressings and topical antibiotics on healing of partial thickness skin wounds in rats. Surg Gynecol Obstet 1973; 136: 958-960.
14. Zoltie N, Verlende T, O'Niell TJ, McKenzie AW. Lyell's syndrome in a burns unit. Burns 1994; 204: 368-370.
15. Halebian P, Corder V, Herndon D. A burn centre experience with toxic epidermal necrolysis. J Burn Care Rehabil 1983; 4: 176-183.
16. Prasad JK, Feller I, Thomson PD. Use of amnion for the treatment of Stevens-Johnson syndrome. J Trauma 1986; 26: 945-946.
17. Kim PS, Goldfarb IW, Gaisford JC. Stevens-Johnson syndrome and toxic epidermal necrolysis: a pathophysiologic review with recommendations for a treatment protocol. J Burn Care Rehabil 1983; 4: 91-100.
18. Halebian PH, Madden MR, Finklestein JL. Improved burn centre survival of patients with toxic epidermal necrolysis managed without corticosteoids. Ann Surg 1986; 204: 503-512.
19. Tegelberg-Stassen MJAM, van Vloten WA, de la Faille HB. Management of non-staphylococcal toxic epidermal necrolysis: follow-up study of 16 case histories. Dermatologica 1990; 180: 124-129.
20. Parsons JM. Management of toxic epidermal necrolysis. Cutis 1985; 36: 305-312.
21. Green D, Law E, Still JM. An approach to the management of toxic epidermal necrolysis in a burns centre. Burns 1993; 19: 411-414.